HIGHLIGHTS
- who: Michael Kasperkiewicz from the University of New South Wales, Australia have published the Article: Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19, in the Journal: (JOURNAL)
- what: Hsps90/70 are involved in AIBDs and COVID-19 in many different ways and, thus, can be important therapeutic targets for both conditions, an ideal scenario during this pandemic (Figure 1).
- future: Exploration of the net effects of especially clinically available Hsp90 blockers in basic studies and clinical trials is needed.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.